DAVIE JOSEPH MD PHD 4

4 · CV THERAPEUTICS INC · Filed Apr 3, 2009

Form 4

Period: 2009-04-02

Director

Transactions

Exercise/Conversion
Common Stock
2009-04-02$10.45/sh+7,500$78,375→ 8,392 total
Tax Payment
Common Stock
2009-04-02$19.92/sh−6,608$131,631→ 892 total
Tax Payment
Common Stock
2009-04-02$19.92/sh−5,430$108,166→ 2,962 total
Exercise/Conversion
Nonqualified Stock Option (right to buy)
2009-04-02−12,500→ 2,500 total
Exercise: $8.74From: 2008-06-20Exp: 2018-05-20→ Common Stock (12,500 underlying)
Exercise/Conversion
Common Stock
2009-04-02$15.60/sh+7,500$117,000→ 7,500 total
Exercise/Conversion
Nonqualified Stock Option (right to buy)
2009-04-02−7,500→ 0 total
Exercise: $10.45From: 2007-06-30Exp: 2017-05-31→ Common Stock (7,500 underlying)
Exercise/Conversion
Common Stock
2009-04-02$8.74/sh+12,500$109,250→ 15,462 total
Tax Payment
Common Stock
2009-04-02$19.92/sh−8,397$167,268→ 7,065 total
Exercise/Conversion
Nonqualified Stock Option (right to buy)
2009-04-02−7,500→ 0 total
Exercise: $15.60From: 2006-07-06Exp: 2016-06-06→ Common Stock (7,500 underlying)

Footnotes (3)

[F1]All shares subject to the option grant were fully vested.
[F2]All shares subject to the option grant were fully vested.
[F3]The shares subject to the option grant vest as to 8.33% of the shares subject to the option grant per month over the twelve (12) month period following the date of grant.

Documents

1 file